The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism

The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism

Background: Secondary hyperparathyroidism (SHPT) is associated with high incidences of cardiovascular disease, bone fracture, and mortality. This study was conducted to demonstrate the effectiveness of cinacalcet treatment on chronic kidney disease-mineral bone disorder (CKD-MBD) markers in chronic...

Full description

Bibliographic Details
Main Authors: Paweena Susantitaphong, Somratai Vadcharavivad, Teerada Susomboon, Wanchana Singhan, Netsiri Dumrongpisutikul, Ketsuda Jakchairoongruang, Somchai Eiam-Ong, Kearkiat Praditpornsilpa
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Renal Failure
Subjects:
cinacalcet
chronic hemodialysis
severe secondary hyperparathyroidism
Online Access:http://dx.doi.org/10.1080/0886022X.2018.1562356

Internet

http://dx.doi.org/10.1080/0886022X.2018.1562356

Similar Items